insulin ninsulina;basal —insulina basal;human —insulina humana;— analogueanálogo de la insulina;— aspartinsulina aspart, insulina asparta (INN);— detemirinsulina detemir;— glargineinsulina glargina;— gluli-sineinsulina glulisina;— lisproinsulina lispro;intermediate-acting —insulina de...
Insulin InfusionRegular InsulinIntroduction The objective of this study was to determine the efficacy and safety of subcutaneous (s.c.) once-daily (OD) glargine insulin, a long-acting insulin, in comparison with a s.c. regular insulin, based on a protocolized sliding scale regimen for ...
(redirected frominsulin, regular) Thesaurus Medical Encyclopedia lis·pro (lĭs′prō′) n. An analog of human insulin, used to treat diabetes. [Alteration oflys(ine)+pro(line)(amino acids whose configuration is reversed from their configuration in insulin).] ...
The patients were divided into 2 groups: subcutaneous insulin glargine + IV regular insulin (group 1) or only IV regular insulin (group 2). Reducing hospital stay in children with diabetic ketoacidosis Because all Type 1 children have to have regular insulin injections and he was so young when...
Exogenous insulins, including the newer biosynthetic insulins (i.e. aspart, detemir, glargine, glulisine, lispro) appear to be excreted into breast milk. Insulin is a protein that is inactivated if taken by mouth. If absorbed, it would be destroyed in the digestive tract of the infant. ...
Glycaemic Control and Hypoglycaemia in Children, Adolescents and Young Adults with Unstable Type 1 Diabetes Mellitus Treated with Insulin Glargine or Inter... In this open study of clinical practice, 142 paediatric patients with type 1 diabetes mellitus (>1 year duration), stratified by age, receiv...
Efficacy of long-acting insulin analog insulin glargine at high dosage for basal-bolus insulin therapy in patients with type 2 diabetes. Attempts to achieve strict glycemic control with basal-bolus insulin therapy required increased dosages of neutral protamine Hagedorn (NPH) insulin. However, high ...
Objectives To determine whether basal‐bolus administration of glargine insulin is a safe and effective alternative treatment compared to the standard continuous rate infusion (CRI) protocol. Design Prospective randomized clinical trial. Setting University teaching hospital. Animals Twenty cats diagnosed with...
Noncritically ill surgical patients with diabetes who were receiving PN were randomized to receive basal glargine insulin or RI-in-PN on day 4 of PN support. Mean blood glucose levels were compared on study days 5-9. The percentages of blood glucose measurements at goal were compared between ...
It is related to increased rates of mortality and morbidity.Objective: The aim of the current work was to compare between glycemic control in single dose long-acting subcutaneous insulin glargine injection and standard continuous regular insulin infusion in the same critical case.Patients and methods...